Eli Lilly and Company (LLY) Pays up to $380M for Alnara Pharmaceuticals, Inc.
7/21/2010 7:10:52 AM
More...
|
Eli Lilly and Company (LLY) To Buy Drug Developer Alnara Pharmaceuticals, Inc.
7/6/2010 7:18:25 AM
More...
|
Alnara Pharmaceuticals, Inc. Flourishes from Altus Pharmaceuticals Inc. (ALTU) Demise
3/5/2010 7:17:45 AM
More...
|
Alnara Pharmaceuticals, Inc. Secures $35 Million in Series B Round
1/28/2010 6:37:29 AM
More...
|
Alnara Pharmaceuticals, Inc. Announces Appointment of Lee R. Brettman, M.D., FACP, to Chief Medical Officer
11/3/2009 9:28:11 AM
More...
|
Lonza Group Ltd. and Alnara Pharmaceuticals, Inc. Enter into Manufacturing Agreement to Produce Liprotamase
10/21/2009 1:41:00 PM
More...
|
Long-Term Data from Landmark Phase 3 Safety and Nutritional Study Evaluating Alnara Pharmaceuticals, Inc.' Liprotamase in Patients with CF to be Presented at 2009 North American Cystic Fibrosis Conference
10/5/2009 9:40:11 AM
More...
|
Alnara Pharmaceuticals, Inc. Announces Promotion of Robert Gallotto to Chief Business Officer
4/16/2009 8:51:44 AM
More...
|
Alnara Pharmaceuticals, Inc. Licenses Worldwide Rights to Liprotamase from Cystic Fibrosis Foundation
3/25/2009 9:14:54 AM
More...
|
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round
10/30/2008 6:28:14 AM
More...
|